on 8th December 2024 at J.N.Tata Auditorium, Indian Institute of Science (IISc), Bangalore, India.

Dr Chirantan Bose MD

Director – Patient Services
Datar Cancer Genetics
India, UK, Germany

  • Dr Chirantan Bose is MD in Pathology and has trained in Hematopathology at Karolinska Institute, Sweden and for Oncopathology at University of Pittsburgh Medical Center USA. He also has a masters in Clinical Genetics from Univ of South Wales, UK. He is pursuing MBA from IIT Bombay
  • He is an International fellow of the College of American Pathologists and is also a senior auditor with the National Accreditation Board for Testing and Calibration Laboratories (NABL) and NABH (National Accreditation Board for Hospitals)
  • Dr Bose is a strategist for medical diagnostic business initiatives and has played lead roles in the establishment and successful operational take-off of several large scale Pathology labs.
  • He has published in several internationally acclaimed medical journals
  • Currently Dr Chirantan Bose leads Clinical operations at Datar Cancer Genetics (MENA, Asia Pac, India Region) and works in the area of Precision Oncology for providing evidence based treatment recommendation in cases of advanced cancers